A major move is in the offing as Cellebrite DI Ltd (CLBT) market cap hits 3.76 billion

Cellebrite DI Ltd (NASDAQ: CLBT) on Friday, soared 1.80% from the previous trading day, before settling in for the closing price of $17.74. Within the past 52 weeks, CLBT’s price has moved between $6.36 and $18.73.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Technology Sector giant saw their annual sales surged by 18.79% over the last five years. The company achieved an average annual earnings per share of 51.02%. With a float of $61.62 million, this company’s outstanding shares have now reached $203.23 million.

The firm has a total of 1008 workers. Let’s measure their productivity. In terms of profitability, gross margin is 84.19%, operating margin of 13.85%, and the pretax margin is -26.72%.

Cellebrite DI Ltd (CLBT) Insider Activity

Observing investor behavior towards Software – Infrastructure industry stocks is more important than anything else. The insider ownership of Cellebrite DI Ltd is 70.39%, while institutional ownership is 33.48%. The most recent insider transaction that took place on Sep 16 ’24, was worth 1,751,000. Before that another transaction happened on Sep 04 ’24, when Company’s Officer proposed sale 8,919 for $16.95, making the entire transaction worth $151,177.

Cellebrite DI Ltd (CLBT) Earnings and Forecasts

According to the Wall Street analysts, stocks earnings will be around 51.02% per share during the next fiscal year.

Cellebrite DI Ltd (NASDAQ: CLBT) Trading Performance Indicators

Cellebrite DI Ltd (CLBT) is currently performing well based on its current performance indicators. A quick ratio of 1.69 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.37. Likewise, its price to free cash flow for the trailing twelve months is 41.46.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.53, a number that is poised to hit 0.07 in the next quarter and is forecasted to reach 0.30 in one year’s time.

Technical Analysis of Cellebrite DI Ltd (CLBT)

Analysing the last 5-days average volume posted by the [Cellebrite DI Ltd, CLBT], we can find that recorded value of 1.53 million was better than the volume posted last year of 1.13 million. As of the previous 9 days, the stock’s Stochastic %D was 69.95%. Additionally, its Average True Range was 0.61.

During the past 100 days, Cellebrite DI Ltd’s (CLBT) raw stochastic average was set at 92.15%, which indicates a significant increase from 73.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.93% in the past 14 days, which was lower than the 41.20% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $16.30, while its 200-day Moving Average is $12.29. Now, the first resistance to watch is $18.41. This is followed by the second major resistance level at $18.76. The third major resistance level sits at $19.08. If the price goes on to break the first support level at $17.74, it is likely to go to the next support level at $17.42. Should the price break the second support level, the third support level stands at $17.07.

Cellebrite DI Ltd (NASDAQ: CLBT) Key Stats

Market capitalization of the company is 3.76 billion based on 205,932K outstanding shares. Right now, sales total 325,110 K and income totals -81,100 K. The company made 95,710 K in profit during its latest quarter, and -23,810 K in sales during its previous quarter.